Delivery Order SPE2D021DA002-SPE2D326F4894
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector two-packs on January 14, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price pricing with no set-aside designation. The delivery order falls under the company's existing Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,045.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery...
- The Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector two-packs. The award, issued on January 15, 2026, with an ultimate completion date of January 16, 2026, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,091.00 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies on January 7, 2026, with completion scheduled for January 8, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,219.75 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The contract, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was awarded on a firm fixed-price basis without set-aside designation, demonstrating the contractor's competitive...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,515.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and carries no set-aside designation, indicating the award was made through open competition. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,045.50. Issued on December 1, 2025, with an ultimate completion date of December 2, 2025, this firm fixed-price delivery order represents a routine procurement under the company's existing pharmaceutical supply contract....
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,613.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued under DMS...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of epinephrine 0.3 mg auto-injector pens (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order carries a firm...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F4894Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack unit). The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, awarded November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, establishing DMS Pharmaceutical Group as a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy. As a critical supplier within the federal pharmaceutical supply chain, the company provides comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally, with emergency medications such as epinephrine auto-injectors representing a key component of its product portfolio delivered to military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/28/26 |